Atrial Fibrillation Trial, Recruiting NCT06078735 Sponsor: Kansas City Heart Rhythm Research Foundation Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06078735
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are able and willing to give their consent to participate
  • People who are already scheduled for a planned medical procedure that involves inserting a needle into a vein (such as a heart procedure for atrial fibrillation), where the treating doctor plans to use a specific wound-closing device called a LockeT or MC to seal the puncture site

Who may not be able to join:

  • People under the age of 18
  • People who are unable or unwilling to give their consent to participate
  • People who are not able to follow the requirements of the study
  • People who are not scheduled for a procedure that involves a needle being inserted into a vein, or planned access to the left side of the heart
  • People whose treating doctor does not use the LockeT or MC device to close the puncture site after the procedure
  • People who are currently pregnant, as confirmed by a urine pregnancy test (this test will be offered to all females of reproductive age as part of the screening process)
  • People in whom the treating doctor finds a blood clot or collection of blood (called a hematoma) at the puncture site before the wound-closing step of the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dhanunjaya Lakkireddy, MD, Kansas City Heart Rhythm Institute

Phone: 816-651-1969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kansas City Heart Rhythm Research Foundation
Registry
ClinicalTrials.gov
Start date
2 October 2023
Est. completion
1 December 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Effectiveness of using the LockeT suture retention device

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov